Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features

noticia |

Kalbasi A., Swisher-Mcclure S., Mitra N., Sunderland R., Smaldone M.C., Uzzo R.G., BekelmanJ.E.

Cancer 2014

BACKGROUND: The 2013 American Urological Association/American Society for Radiation Oncology consensus guidelines recommend offering adjuvant radiotherapy (RT) after radical prostatectomy in patients with high-risk pathologic features for recurrence. In the current study, the authors examined practice patterns of adjuvant RT use in patients with elevated pathologic risk factors over a time period spanning the publication of supporting randomized evidence. METHODS: Using the National Cancer Data Base, a total of 130,681 patients were identified who underwent surgical resection for prostate cancer between 2004 and 2011 with at least 1 of the following pathologic risk factors for early biochemical failure: pT3a disease or higher, positive surgical margins and/or lymph node-positive disease. Using multivariable logistic regression, the authors examined factors associated with adjuvant RT use including patient, clinical, demographic, and temporal characteristics…(vermás)


1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)